Employing this contrast-enhanced in-phase Dixon sequence may "help address a current challenge in routine clinical breast MRI interpretation," the authors of this AJR article concluded. Taylor-Cho, ...

Contrast-enhanced in-phase Dixon sequence could reduce the need for correlation among other imaging modalities to better identify areas of prior biopsy during breast MRI interpretation, according to a ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, ...

Magnetic Resonance Imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast ...

Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety ...